Hartmann D, Lunell N O, Friedrich G, Rane A
Pharma Clinical Research, F. Hoffmann-La Roche & Co. Ltd, Basle, Switzerland.
Br J Clin Pharmacol. 1988 Aug;26(2):183-6. doi: 10.1111/j.1365-2125.1988.tb03385.x.
The excretion of tiapamil in breast milk was studied in six lactating mothers (3-7 days post partum) following a single oral 600 mg dose of the drug. The milk/plasma ratio of tiapamil derived from the areas under the plasma and milk concentration-time curves was 0.44 +/- 0.10 mean +/- s.d.). Assuming an intake of 350 ml of milk during a dosing interval of 12 h, the newborn would be exposed at the maximum to 0.053 mg tiapamil. This small amount does not represent a risk for the baby.
在6名产后3 - 7天的哺乳期母亲单次口服600毫克替帕米后,研究了替帕米在母乳中的排泄情况。根据血浆和乳汁浓度 - 时间曲线下面积得出的替帕米乳汁/血浆比值为0.44±0.10(均值±标准差)。假设在12小时的给药间隔期间摄入350毫升乳汁,新生儿最大暴露量为0.053毫克替帕米。如此少量对婴儿不构成风险。